Strategic clinical research consulting services are most effective when a sponsor partners with a team that’s experienced and focused on optimizing a sponsor’s resources. At PharPoint, we’re passionate about helping our clients improve global health, not just the bottom line. We use the hard earned knowledge we’ve obtained from decades of clinical research to offer oversight, risk mitigation, and study optimization.
Strategic Consulting
Clinical research consultants passionate about helping you improve global health
Bringing promising innovations to patients
PharPoint’s experience is rooted in a consultative, collaborative approach that values what’s best for your study, and ultimately, for the patients whose lives are affected by your therapies. PharPoint is a team of clinical trial consultants and industry experts with full-service capabilities. We can advise clients at the beginning of a study or during implementation in a fully consultative role or actively initiate change through our own functional teams.
We’ve provided statistical representation across
FDA divisions
Our department leaders have seen it all, with clinical research experience averaging
years
EXPLORE
Our comprehensive clinical research consulting services include:
- Clinical development planning
- CRO oversight and trial support
- Global operational strategies
- Safety assessments
- Regulatory submission support
- Evaluation of prior study results
"You know a consulting relationship is successful when the expertise provided is not just another service offering, but represents a vested desire to advance the sponsor's clinical research."
Jennifer A. Elder, PhD. PharPoint Research CSO.
Meet a PharPoint Clinical Research Consultant
Moya Hawkins, Senior Director of Consulting Operations
Ms. Hawkins has been in the CRO industry since 1995 managing Phase 1-4 clinical trials across both EDC and paper platforms, including global, multilingual Phase 3-4 studies.
Her clinical research experience includes serving on EDC steering committees within several companies, application validation and serving as a point person for the implementation of the transition from paper based studies to EDC studies for several companies. She was an integral part of the Medrio implementation team at PharPoint Research and serves as a platform expert within the company. Ms. Hawkins’ extensive experience includes managing a multi-country, emergency use protocol, studies with special patient populations, and salvage therapy studies. Ms. Hawkins also has participated in industry related committees.